Brigade Strongly Supports Glass Lewis Recommendation to Vote AGAINST Kindred Healthcare Merger

NEW YORK--(BUSINESS WIRE)--Brigade Capital Management, LP (“Brigade”), on behalf of funds managed by it, announced today that it strongly supports the recommendation by leading independent institutional investor advisor, Glass Lewis, to vote AGAINST the Kindred Healthcare’s 2018 merger-related proxy proposals. In its report, Glass Lewis highlights its concerns regarding the questionable timing and unattractive financial terms of the transaction, as well as the excessive senior executive compensation that would become payable upon shareholder approval of the company’s “Golden Parachute” proxy proposal. Brigade urges all Kindred shareholders to read the Glass Lewis report and to vote: